课题基金 / 基金详情

MECHANISMS OF CHRONIC PROSTATITIS

MECHANISMS OF CHRONIC PROSTATITIS
慢性前列腺炎的机制
批准号:
2018220
负责人:
DON KREUTZER
金额:
$22.99万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-07-07 至 2001-05-31

项目摘要

项目成果

DON KREUTZER的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION Currently, virtually nothing is known about the existence and role of T lymphocytes, mast cells and their products in non bacterial chronic prostatitis (NBCP). Thus, it is essential that a systematic characterization of these cells and their products in NBCP be undertaken to fill this major gap in our knowledge of this inflammatory disease. Thus, we propose to: 1) systematically characterize T lymphocyte subpopulations in NBCP and non NBCP patients (for clinical criteria, see Patient Population below); 2) determine the role of CD4 Th2-related cytokines, particularly IL3 in promoting mast cell growth and differentiation in NBCP, and 3) to determine the role of mast cells and their products in NBCP and non NBCP. We hypothesize that NBCP is an inflammatory disease of the prostate that results from an imbalance of specific T-lymphocyte subpopulations. To test this hypothesis, we have developed the following specific aims: (1) to isolate, characterize and correlate T cells and T cell clones from fluids (blood, urine, prostate fluids) and tissue from NBCP, non NBCP and normal patient; (2) to characterize and correlate the distribution of CD4 Th1 and CD4 Th2 lymphocytes and associated cytokines in fluids (blood, urine, prostate fluids) and tissue from NBCP, non NBCP and normal patients; and (3) to characterize and correlate the distribution of mast cells and mast cell-related factors in NBCP, non NBCP and normal patients.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A novel inline platform provides an advanced drug delivery device foroptimized diabetes therapy
  • 批准号:
    10736126
  • 项目类别:
  • 资助金额:
    $68.79万
  • 财政年份:
    2023
  • 负责人:
    DON KREUTZER
  • 依托单位:
Development and Validation of Novel Coatings that Extend Glucose Sensor Accuracy and Lifespan in vivo
Use of Stem Cells to Enhance and Extend Continuous Glucose Monitoring in Vivo
Impact of the Vascular System and CGM
海外基金